Searching map area
Bevacizumab
? TBD
Medication
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Subject of
14
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies
scientific article
Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation
scientific article published on 11 April 2012
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study
scientific article
What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
scientific article published on 01 April 2007
Improved survival with bevacizumab in advanced cervical cancer
scientific article
Optic neuropathy in patients with glioblastoma receiving bevacizumab
scientific article published on 01 July 2010
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I study
scientific article
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
scientific article
Bevacizumab: optimal dose, schedule, and duration of therapy.
scientific article
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
scientific article published on 17 February 2018
4 more
Lists
0
Join to rate

Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell...

Instance of
type of chemical entity
Subclass of
Chemical compound
Wikidata